Ehud Reich

557 total citations
12 papers, 135 citations indexed

About

Ehud Reich is a scholar working on Ophthalmology, Molecular Biology and Epidemiology. According to data from OpenAlex, Ehud Reich has authored 12 papers receiving a total of 135 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Ophthalmology, 5 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Ehud Reich's work include Ocular Oncology and Treatments (4 papers), Retinal Diseases and Treatments (3 papers) and Retinal and Optic Conditions (2 papers). Ehud Reich is often cited by papers focused on Ocular Oncology and Treatments (4 papers), Retinal Diseases and Treatments (3 papers) and Retinal and Optic Conditions (2 papers). Ehud Reich collaborates with scholars based in Israel, United Kingdom and India. Ehud Reich's co-authors include Hadas Stiebel‐Kalish, Mandeep S. Sagoo, Michael Bach, Ruth Axer‐Siegel, Dov Weinberger, John L. Hungerford, Ayelet Priel, Yael Nisgav, Guy Ben Simon and Yoav Gothilf and has published in prestigious journals such as Ophthalmology, International Journal of Radiation Oncology*Biology*Physics and American Journal of Ophthalmology.

In The Last Decade

Ehud Reich

12 papers receiving 128 citations

Peers

Ehud Reich

OPHTH

MB

EPIDE

DERMA

NEURO

Ilaria Tanini Italy

Danielle S. Rudich United States

J I Patel United Kingdom

Aisha Khaleeq United States

Yong Y Kim United States

Niranjan Manoharan United States

Ian Simmons United Kingdom

S Longstaff United Kingdom

David Warrow United States

Sujit Itty United States

Ilaria Tanini Italy

Ehud Reich

26 ×0.3

OPHTH

48 ×1.1

MB

25 ×0.6

EPIDE

0 ×0.0

DERMA

7 ×0.5

NEURO

Citations per year, relative to Ehud Reich Ehud Reich (= 1×) peers Ilaria Tanini

Countries citing papers authored by Ehud Reich

Since Specialization

Citations

This map shows the geographic impact of Ehud Reich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehud Reich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehud Reich more than expected).

Fields of papers citing papers by Ehud Reich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ehud Reich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehud Reich. The network helps show where Ehud Reich may publish in the future.

Co-authorship network of co-authors of Ehud Reich

This figure shows the co-authorship network connecting the top 25 collaborators of Ehud Reich. A scholar is included among the top collaborators of Ehud Reich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ehud Reich. Ehud Reich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Reich, Ehud, et al.. (2020). Uveitis Induced by Brentuximab Vedotin-A Novel Adverse Response to Antibody-Drug Conjugate Therapy. 2020(3). 1–3. 2 indexed citations

2.

Reich, Ehud, et al.. (2020). Telemedicine comes of age during coronavirus disease 2019 (COVID-19): An international survey of oculoplastic surgeons. European Journal of Ophthalmology. 31(6). 2881–2885. 7 indexed citations

3.

Reich, Ehud, et al.. (2019). Efficacy of Vismodegib for the Treatment of Orbital and Advanced Periocular Basal Cell Carcinoma. American Journal of Ophthalmology. 207. 62–70. 25 indexed citations

4.

Avisar, Inbal, et al.. (2019). Non-neovascular subretinal fluid secondary to choroidal osteoma controlled with intravitreal aflibercept – A case report. 2(2). 31–33. 1 indexed citations

5.

Papastefanou, Vasilios P., P N Plowman, Ehud Reich, et al.. (2018). Analysis of Long-term Outcomes of Radiotherapy and Verteporfin Photodynamic Therapy for Circumscribed Choroidal Hemangioma. Ophthalmology Retina. 2(8). 842–857. 19 indexed citations

6.

Reich, Ehud, et al.. (2017). Visual Loss from Choroidal Melanoma Mimicking Neurological Syndromes. Case Reports in Neurology. 9(1). 31–35. 1 indexed citations

7.

Poon, Daniel, Ehud Reich, Victoria M. Smith, et al.. (2015). Ruthenium-106 Plaque Brachytherapy in the Primary Management of Ocular Medulloepithelioma. Ophthalmology. 122(9). 1949–1951. 9 indexed citations

8.

Reich, Ehud, et al.. (2013). Third-Generation Elisa Thyrotropin-Receptor Antibody Levels as an Adjuvant Tool to Guide Management of Patients with Graves Orbitopathy. Endocrine Practice. 20(2). 145–149. 7 indexed citations

9.

Stiebel‐Kalish, Hadas, Ehud Reich, Gad D. Vatine, et al.. (2012). Gucy2f zebrafish knockdown – a model for Gucy2d-related leber congenital amaurosis. European Journal of Human Genetics. 20(8). 884–889. 23 indexed citations

10.

Goldenberg‐Cohen, Nitza, Olga Dratviman‐Storobinsky, Ehud Reich, et al.. (2011). DOES HAPTOGLOBIN GENOTYPE AFFECT EARLY ONSET OF DIABETIC RETINOPATHY IN PATIENTS WITH TYPE 2 DIABETES?. Retina. 31(8). 1574–1580. 4 indexed citations

11.

Stiebel‐Kalish, Hadas, Ehud Reich, Z. Harry Rappaport, et al.. (2011). Visual Outcome in Meningiomas Around Anterior Visual Pathways Treated With Linear Accelerator Fractionated Stereotactic Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 82(2). 779–788. 14 indexed citations

12.

Kramer, Michal, Ruth Axer‐Siegel, Tareq Jaouni, et al.. (2010). BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION RELATED TO INFLAMMATORY DISEASES. Retina. 30(6). 938–944. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact